Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
Clinical trial NCT05270057 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05270057
- Sponsor
- Medical College of Wisconsin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-26
- Primary completion
- 2025-05-28
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.